Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patients
Latest Information Update: 26 Aug 2022
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms ANTIICIPATE
- 26 Aug 2022 Status changed from recruiting to discontinued.
- 11 Dec 2020 New trial record